๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Restenosis after transluminal coronary angioplasty: A risk factor analysis

โœ Scribed by Arora, Rohit R. ;Konrad, Katherine ;Badhwar, Kavita ;Hollman, Jay


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
619 KB
Volume
19
Category
Article
ISSN
0098-6569

No coin nor oath required. For personal study only.

โœฆ Synopsis


In order to determine the relationship of restenosis following percutaneous transluminal coronary angioplasty (PTCA) to risk factors such as hypercholesterolemia, hyperglycemia, smoking, and weight, we performed a univariate analysis to test the association of these variables with restenosis in 723 patients who had percutaneous transluminal coronary angioplasty and follow-up catheterization.

Cholesterol levels were higher in younger and female subjects (<O.OOOl). Initial cholesterol did not predict restenosis, and follow-up cholesterol levels showed an inverse relationship with restenosis (P <.02). There was a trend (P <.09) toward decreased restenosis in those who were active smokers at the time of follow-up catheterization. No differences were seen in diabetics with hyperglycemia, in both treated and untreated groups (P = NS). A stepwise multiple logistic regression was used to simultaneously test the association of the above risk factor variables to restenosis. None of the interactions were found to be significant, except cholesterol at follow-up (P = .001).

Therefore, the status of serum cholesterol, blood sugar, smoking, and weight during the time of PTCA and at follow-up catheterization may be unimportant in predicting restenosis. Thus, we conclude 1) that to better determine the effect of these variables on restenosis, they should be estimated at times other than follow-up and 2) that the pathophysiological mechanism of restenosis may have different risk factors than progression of atherosclerotic coronary artery disease.


๐Ÿ“œ SIMILAR VOLUMES


Coronary artery aneurysm formation follo
โœ Walford, Gary D. ;Midei, Mark G. ;Aversano, Thomas R. ;Gottlieb, Sidney O. ;Chew ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 598 KB

Restenosis following coronary angioplasty can usually be treated effectively and safely by repeated angioplasty. However, the presence of a complex lesion morphology may bias the clinician away from angioplasty toward either recommending bypass surgery or continuing medical therapy alone in spite of

Effectiveness of LDL-apheresis in preven
โœ Hiroshi Yamaguchi; Young J. Lee; Hiroyuki Daida; Hisashi Yokoi; Hiroshi Miyano; ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 320 KB

To investigate the efficacy of reducing plasma lipoprotein(a) (Lp(a)) as well as low density lipoprotein cholesterol (LDL-C) levels on the prevention of restenosis after PTCA, LDL-apheresis was attempted on a total of 54 patients at six institutions. LDL-apheresis using a dextran sulfate cellulose c

DEPOSITION OF PG-M/VERSICAN IS A MAJOR C
โœ MATSUURA, RITSUKO; ISAKA, NAOKI; IMANAKA-YOSHIDA, KYOKO; YOSHIDA, TOSHIMICHI; SA ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 601 KB

To clarify the mechanisms of restenosis, restenotic human tissue specimens obtained by directional coronary atherectomy (DCA) in 43 patients were immunohistochemically analysed for cell proliferation and deposition of PG-Mlversican, an important extracellular matrix proteoglycan of the vessel wall.